pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,159 catalysts · 5,159 phase readout · 2,286 8k filing · 315 pdufa · 257 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 0 catalysts2026-07-30: 14 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 13 catalysts2026-08-05: 16 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 1 catalyst2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 0 catalysts2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: phase readout×clear all
type
  • phase readout5,159
  • 8k filing2,286
  • pdufa315
  • earnings257
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›RECRUITINGphase readoutNCT06149819: Chest Pain Nurse Track

Sponsor: University Hospital, Grenoble. Phase: NA. Conditions: Chest Pain

full page →ctgov ↗
›WITHDRAWNphase readoutNCT05170828: Cryopreserved MMUD BM With PTCy for Hematologic Malignancies

Sponsor: Ossium Health, Inc.. Phase: PHASE1. Conditions: Acute Leukemia, Myelodysplastic Syndromes, T-lymphoblastic Lymphoma, Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Acute Biphenotypic Leukemia, Acute Undifferentiated Leukemia

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT02574728: Sirolimus in Combination With Metronomic Chemotherapy in Children With Recurrent and/or Refractory Solid and CNS Tumors

Sponsor: Emory University. Phase: PHASE2. Conditions: Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT06024928: Automated Insulin Delivery (AID) for Basal Insulin Titration in Type 2 Diabetes

Sponsor: University of Virginia. Phase: NA. Conditions: Type 2 Diabetes

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07466771: Art Education and Creativity in Midwifery Students

Sponsor: Selcuk University. Phase: NA. Conditions: Creativity and Mindfulness

full page →ctgov ↗
›COMPLETEDphase readoutNCT05040971: Research Study Looking at How Well Semaglutide Works in People Living With Obesity and Prediabetes

Sponsor: Novo Nordisk A/S. Phase: PHASE3. Conditions: Obesity

full page →ctgov ↗
›RECRUITINGphase readoutNCT06027671: Structured Peer-delivered ART and Reentry Community Strategy

Sponsor: Johns Hopkins University. Phase: NA. Conditions: Retention in Care

full page →ctgov ↗
›RECRUITINGphase readoutNCT06747871: Opioids, Low Nicotine Cigarettes, and Chronic Pain

Sponsor: Duke University. Phase: NA. Conditions: Chronic Pain, Tobacco Use, Opioid Substitution Treatment

full page →ctgov ↗
›COMPLETEDphase readoutNCT03490071: Long-term Follow up of Patients With Longstanding Hip and Groin Pain

Sponsor: Lund University. Phase: . Conditions: Hip Pain Chronic

full page →ctgov ↗
›RECRUITINGphase readoutNCT07185971: PAVE (Parallactic Visual-Field Enhancement) System for Treatment of Chronic Visual Field Loss Due to Stroke, Traumatic Brain Injury, or Brain Surgery

Sponsor: NeuroAEye LLC. Phase: NA. Conditions: Homonymous Hemianopsia, Homonymous Quadrantanopia

full page →ctgov ↗
›RECRUITINGphase readoutNCT06886971: Strategies to AchieVe Viral Suppression for Youth With HIV

Sponsor: Johns Hopkins University. Phase: NA. Conditions: Human Immunodeficiency Virus (HIV) Infection

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07559071: Effects of Emotional Freedom Technique and Music Therapy in High-Risk Pregnancy

Sponsor: Selcuk University. Phase: NA. Conditions: Preterm Premature Rupture of Membranes (PPROM), Premature Rupture of Membranes (PROM), High-Risk Pregnancy

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07390344: VIATORR® TIPS Study Evaluating 6-10mm Diameters (VIATIPS)

Sponsor: W.L.Gore & Associates. Phase: . Conditions: Ascites, Variceal Bleeding, Portal Hypertension Related to Cirrhosis

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT02579044: Phase I/II Trial of Everolimus in Combination With Lonafarnib in Progeria

Sponsor: Boston Children's Hospital. Phase: PHASE1. Conditions: Progeria

full page →ctgov ↗
›RECRUITINGphase readoutNCT07435909: Bupivacaine for Postoperative Pain After Laparoscopic Hysterectomy

Sponsor: Serkan Kumbasar. Phase: NA. Conditions: Postoperative Pain

full page →ctgov ↗
›RECRUITINGphase readoutNCT07396909: A First-in-Human Single and Multiple Ascending Dose Study of MT-701

Sponsor: Mirador Therapeutics, Inc.. Phase: PHASE1. Conditions: Healthy Volunteers

full page →ctgov ↗
›RECRUITINGphase readoutNCT00001532: Role of Genetic Factors in the Development of Lung Disease

Sponsor: National Heart, Lung, and Blood Institute (NHLBI). Phase: . Conditions: Cystic Fibrosis, Pulmonary Fibrosis, Tuberous Sclerosis, Asthma, Pulmonary Sarcoidosis

full page →ctgov ↗
›COMPLETEDphase readoutNCT03645863: Effects of Iron Supplements on the Pharmacokinetics of MT-6548

Sponsor: Tanabe Pharma Corporation. Phase: PHASE3. Conditions: Healthy

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07447063: The Impact of Dietary Salt on the Severity of Eczema

Sponsor: University of California, San Francisco. Phase: PHASE4. Conditions: Eczema, Atopic Dermatitis

full page →ctgov ↗
›RECRUITINGphase readoutNCT07460687: Westlake Frequent-sampling Cohort

Sponsor: Westlake University. Phase: . Conditions: Health Adults, Stability of Microbiome

full page →ctgov ↗
›RECRUITINGphase readoutNCT06999187: A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas

Sponsor: Dren Bio. Phase: PHASE1. Conditions: Triple Negative Breast Cancer, HER2-negative Breast Cancer, Non Small Cell Lung Cancer, Cervical Cancer, Castrate Resistant Prostate Cancer, Pancreatic Ductal Adenocarcinoma, Head-and-neck Squamous Cell Carcinoma, Endometrial Cancer, Ovarian Cancer, Gastric Cancer, Gastroesophageal-junction Cancer, Urothelial Carcinoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT07474987: Portable VR-based Chromatic Pupilloperimeter for Diagnosis and Monitoring of Traumatic Brain Injury

Sponsor: Sheba Medical Center. Phase: . Conditions: Traumatic Brain Injury (TBI) Patients, Healthy Participants, Non-TBI Trauma

full page →ctgov ↗
›COMPLETEDphase readoutNCT06918587: A Comparative Evaluation of Pharmacokinetics and Immunogenicity.

Sponsor: Kashiv BioSciences, LLC. Phase: PHASE1. Conditions: Febrile Neutropenia

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07521787: Prognostic Value of Metabolic Characteristics in High-Risk Populations for Acute Kidney Injury After Cardiac Surgery

Sponsor: Shanghai Zhongshan Hospital. Phase: . Conditions: Cardiac Surgery Associated - Acute Kidney Injury, Critical Illness

full page →ctgov ↗
›TERMINATEDphase readoutNCT05814666: Activity and Safety of Danvatirsen and Pembrolizumab in HNSCC

Sponsor: Flamingo Therapeutics NV. Phase: PHASE2. Conditions: HNSCC

full page →ctgov ↗
›RECRUITINGphase readoutNCT06561451: Live Birth Rate Between ICSI and AOA and ICSI Alone in Patients With Severe Teratospermia

Sponsor: ShangHai Ji Ai Genetics & IVF Institute. Phase: NA. Conditions: Male Infertility, Teratospermia

full page →ctgov ↗
›COMPLETEDphase readoutNCT02793453: Antimicrobial Peptides in Periodontitis

Sponsor: CHU de Reims. Phase: NA. Conditions: Periodontal Disease : Chronic Periodontitis

full page →ctgov ↗
›RECRUITINGphase readoutNCT07302802: Efficacy of Semaglutide s.c. Once-weekly on Weight Loss and Management in Adolescents With Monogenic Obesity in Clinical Practice

Sponsor: Prof. Dr. Martin Wabitsch. Phase: . Conditions: Monogenic Obesity

full page →ctgov ↗
›RECRUITINGphase readoutNCT04984837: Study of Lacutamab in Peripheral T-cell Lymphoma

Sponsor: The Lymphoma Academic Research Organisation. Phase: PHASE2. Conditions: Peripheral T Cell Lymphoma, Relapse/Recurrence

full page →ctgov ↗
›RECRUITINGphase readoutNCT06362837: Evaluation of REACTS-IN, an Intervention to Improve Nutrition, Hygiene, and Sexual and Reproductive Health Services

Sponsor: McGill University. Phase: NA. Conditions: Stunting, Gender Equality, Acceptability of Health Care, Diet; Deficiency, Empowerment

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07444645: PREDICTT Clinical Trial: Prospective Evaluation Of Pressure-Enabled Delivery And Alterations In CT-Based Tumor-To-Normal Liver Ratio And Tumor Dose Using The Trinav Infusion System

Sponsor: M.D. Anderson Cancer Center. Phase: NA. Conditions: Tumor, Liver

full page →ctgov ↗
›COMPLETEDphase readoutNCT07495345: Feasibility Study of a Novel Automated Slit Lamp Camera (Lightfield Medical Ophthalmic Camera Model Vscan001)

Sponsor: Lightfield Medical. Phase: NA. Conditions: Anterior Segment of Eye

full page →ctgov ↗
›RECRUITINGphase readoutNCT07203339: Home-based Transcranial Direct Current Stimulation (tDCS) Compared to Duloxetine: Non-inferiority Clinical Trial (FIBROSTIM)

Sponsor: Hospital de Clinicas de Porto Alegre. Phase: NA. Conditions: Fibromyalgia (FM), tDCS, Duloxetine, BDNF, EEG

full page →ctgov ↗
›COMPLETEDphase readoutNCT04217239: A Comparison Between Ivor-Lewis and McKeown Minimally Invasive Esophagectomy

Sponsor: The Second Hospital of Shandong University. Phase: NA. Conditions: Esophageal Cancer

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06232577: 5x-Multiplier vs 3-Tier Model for Discharge Opioid Prescriptions After Intra-abdominal Cancer Surgery: A Randomized Clinical Trial

Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: Intra-abdominal Cancer

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03520101: Comparison of the Balloon-Expandable Edwards Valve and Self-Expandable CoreValve Evolut R or Evolut PRO System for the Treatment of Small, Severely Dysfunctional Surgical Aortic Bioprotheses. The 'LYTEN' Trial

Sponsor: Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec. Phase: NA. Conditions: Aortic Valve Stenosis, Regurgitation, Aortic, Prosthesis Failure

full page →ctgov ↗
›COMPLETEDphase readoutNCT06618781: Perioperative Effects of Lateral Quadratus Lumborum Block in Percutaneous Transhepatic Cholangiography

Sponsor: Ankara Etlik City Hospital. Phase: NA. Conditions: Opioid Consumption, Visual Analog Score, Demographic Data, Rescue Analgesic Status and Time

full page →ctgov ↗
›COMPLETEDphase readoutNCT07279181: TVS, SHG, and MRI in Uterine Niche

Sponsor: International Peace Maternity and Child Health Hospital. Phase: . Conditions: Uterine Niche

full page →ctgov ↗
›RECRUITINGphase readoutNCT05708430: Tolerance of Intra-articular Injection Autologous Stromal Vascular Fraction for the Treatment of Rhizarthrosis

Sponsor: University Hospital, Rouen. Phase: PHASE2. Conditions: Rhizarthrosis

full page →ctgov ↗
›COMPLETEDphase readoutNCT03166930: Evaluation of a Spasticity Management Program for People With Multiple Sclerosis

Sponsor: VA Office of Research and Development. Phase: NA. Conditions: Multiple Sclerosis

full page →ctgov ↗
›RECRUITINGphase readoutNCT06712628: A Comparison Study of Persistence of UPadacitinib vs. TNF-inhibitoRs In a German Real-world SettING

Sponsor: AbbVie. Phase: . Conditions: Moderate to Severe Rheumatoid Arthritis

full page →ctgov ↗
›RECRUITINGphase readoutNCT07525765: AI-assisted Decision-making of Reoperation for Postoperative Bleeding of Gastric Cancer

Sponsor: First Affiliated Hospital of Zhejiang University. Phase: . Conditions: Gastrectomy for Gastric Cancer, Gastric Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT06409065: Psycho-Spiritual Management for Patients With Advanced Cancer and Their Family Caregivers

Sponsor: M.D. Anderson Cancer Center. Phase: NA. Conditions: Cancer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07032571: Reset: Enhancing Weight Loss in a Digital Intervention

Sponsor: Stanford University. Phase: NA. Conditions: Obesity, Overweight, Weight Loss, Health Behavior, Lifestyle Intervention

full page →ctgov ↗
›RECRUITINGphase readoutNCT07343271: Dual-energy CT vs. MRI in the Evaluation of Squamous Cell Carcinomas of the Oral Cavity and Oropharynx

Sponsor: University Hospital, Strasbourg, France. Phase: . Conditions: Oral Squamous Cell Carcinoma, Oropharyngeal Squamous Cell Carcinoma

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07364071: Strategic Endocrine Therapy and Targeted Radiotherapy for Prostate Cancer

Sponsor: University of California, San Diego. Phase: PHASE2. Conditions: Prostate Adenocarcinoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT05892744: Establishing Multimodal Brain Biomarkers for Treatment Selection in Depression

Sponsor: University of Texas at Austin. Phase: PHASE4. Conditions: Major Depressive Disorder, Chronic Major Depression, Recurrent

full page →ctgov ↗
›COMPLETEDphase readoutNCT06254144: Neuroimaging Study for Decoding Emotional States and Identifying Neural Circuits to Disengage From Negative Thinking

Sponsor: Laureate Institute for Brain Research, Inc.. Phase: . Conditions: Depressive Disorder, Major

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07432009: Orthopedic Procedures and Postoperative Delirium in Older Adults in the Czech Republic

Sponsor: Tomas Bata Hospital, Czech Republic. Phase: . Conditions: Frailty, Cognitive Impairment, Older Adults, Hip Arthroplasty, Postoperative Delirium

full page →ctgov ↗
›COMPLETEDphase readoutNCT00003809: Cisplatin With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic or Recurrent Head and Neck Cancer

Sponsor: Eastern Cooperative Oncology Group. Phase: PHASE3. Conditions: Head and Neck Cancer

full page →ctgov ↗
← prev
page 19 of 104
next →